In the BioHarmony Drug Report Database

"Preview" Icon

Cefamandole nafate

Mandol (cefamandole nafate) is a small molecule pharmaceutical. Cefamandole nafate was first approved as Mandol on 1982-01-01. It is used to treat bacterial pneumonia, bacterial skin diseases, escherichia coli infections, haemophilus infections, and infectious bone diseases amongst others in the USA.

 

Trade Name

 

Mandol
 

Common Name

 

cefamandole nafate
 

ChEMBL ID

 

CHEMBL1618
 

Indication

 

bacterial pneumonia, bacterial skin diseases, escherichia coli infections, haemophilus infections, infectious bone diseases, klebsiella infections, proteus infections, soft tissue infections, staphylococcal infections, streptococcal infections, urinary tract infections
 

Drug Class

 

Cephalosporins

Image (chem structure or protein)

Cefamandole nafate structure rendering